Biochemically altered human erythrocytes as a carrier for targeted delivery of primaquine: An in vitro study

Archives of Pharmacal Research

Volumn 34, Issue 4, 2011, Pages 563-571

  Alanazi, Fars K ^a   Harisa, Gamal El Din I ^a   Maqboul, Ahmad ^a   Abdel Hamid, Magdi ^a   Neau, Steven H ^b   Alsarra, Ibrahim A ^a,c  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b UNIVERSITY OF THE SCIENCES   (United States)

^c KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Carrier erythrocytes; Glutathione; Malondialdehyde; Osmotic fragility; Primaquine; Protein carbonyl

Indexed keywords

DRUG CARRIER; GLUTATHIONE; HEMOGLOBIN; MALONALDEHYDE; PRIMAQUINE;

ARTICLE; DRUG RELEASE; ELECTRON MICROSCOPY; ERYTHROCYTE; ERYTHROCYTE DISORDER; ERYTHROCYTE FRAGILITY; HEMATOLOGICAL PARAMETERS; HUMAN; HUMAN CELL; INCUBATION TIME; OXIDATIVE STRESS; PROTEIN CARBONYLATION;

ANTIMALARIALS; CELL CULTURE TECHNIQUES; CELLS, CULTURED; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG CARRIERS; ENDOCYTOSIS; ERYTHROCYTE COUNT; ERYTHROCYTES; GLUTATHIONE; HEMOGLOBINS; HUMANS; MALONDIALDEHYDE; MICROSCOPY, ELECTRON, SCANNING; OSMOTIC FRAGILITY; OXIDATION-REDUCTION; OXIDATIVE STRESS; PRIMAQUINE; PROTEIN CARBONYLATION; SURFACE PROPERTIES;

EID: 79960405094     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-011-0406-7     Document Type: Article

References (45)

1. Adams, T., Alanazi, F., and Lu, D. R., Safety and utilization of blood components as therapeutic delivery systems. Curr. Pharm. Biotechnol., 4, 275-282 (2003). (Pubitemid 37220860)
2. Becker, K., Tilley, L., Vennerstrom, J. L., Roberts, D., Rogerson, S., and Ginsburg, H., Oxidative stress in malaria parasite-infected erythrocytes: host-parasite interactions. Int. J. Parasitol., 34, 163-189 (2004). (Pubitemid 38229822)
3. Beppu, M., Inoue, M., Ishikawa, T., and Kikugawa, K., Presence of membrane-bound proteinases that preferentially degrade oxidatively damaged erythrocyte membrane proteins as secondary antioxidant defense. Biochim. Biophys. Acta, 1196, 81-87 (1994). (Pubitemid 24372348)
4. Bhadra, D., Yadav, A. K., Bhadra, S., and Jain, N. K., Glycodendrimeric nanoparticulate carriers of primaquine phosphate for liver targeting. Int. J. Pharm., 295, 221-233 (2005). (Pubitemid 40558805)
5. Bukowska, B., Rychlik, B., Krokosz, A., and Michalowicz, J., Phenoxyherbicides induce production of free radicals in human erythrocytes: oxidation of dichlorodihydrofluorescine and dihydrorhodamine 123 by 2, 4-D-Na and MCPA-Na. Food Chem. Toxicol., 46, 359-367 (2008). (Pubitemid 350235780)
6. Chiu, D., Kuypers, F., and Lubin, B., Lipid peroxidation in human red cells. Semin. Hematol., 26, 257-276 (1989). (Pubitemid 19271286)
7. Dierling, A. M., and Cui, Z., Targeting primaquine into liver using chylomicron emulsions for potential vivax malaria therapy. Int. J. Pharm., 303, 143-152 (2005). (Pubitemid 41318031)
8. Dumaswala, U. J., Wilson, M. J., José, T., and Daleke, D. L., Effect of a glycerol-containing hypotonic medium on erythrocyte phospholipid asymmetry and aminophospholipid transport during storage. Biochim. Biophys. Acta, 1330, 265-273 (1997). (Pubitemid 27522784)
9. Eichler, H. G., Raffesberg, W., Gasic, S., Korn, A., and Bauer, K., Release of vitamin B12 from carrier erythrocytes in vitro. Res. Exp. Med (Berl)., 185, 341-344 (1985). (Pubitemid 15040809)
10. Gopal, V. S., Ranjith Kumar, A., Usha, A. N., Karthik, A., and Udupa, N., Effective drug targeting by erythrocytes as carrier systems. Curr. Trends Biotech. Pharm., 1, 18-33 (2007).
11. Gutiérrez Millán, C., Zarzuelo Castañeda, A., Sayalero Marinero, M. L., and Lanao, J. M., Factors associated with the performance of carrier erythrocytes obtained by hypotonic dialysis. Blood Cells Mol. Dis., 33, 132-140 (2004). (Pubitemid 39094719)
12. Gutiérrez Millán, C., Bax, B. E., Castañeda, A. Z., Marinero, M. L., and Lanao, J. M., In vitro studies of amikacin-loaded human carrier erythrocytes. Transl. Res., 152, 59-66 (2008).
13. Hamidi, M., Tajerzadeh, H., Dehpour, A. R., Rouini, M. R., and Ejtemaee-Mehr, S., In vitro characterization of human intact erythrocytes loaded by enalaprilat. Drug Deliv., 8, 223-230 (2001). (Pubitemid 33104935)
14. Hamidi, M., Zarrin, A., Foroozesh, M., and Mohammadi-Samani, S., Applications of carrier erythrocytes in delivery of biopharmaceuticals. J. Control. Release, 118, 145-160 (2007a). (Pubitemid 46329734)
15. Hamidi, M., Zarrin, A. H., Foroozesh, M., Zarei, N., and Mohammadi-Samani, S., Preparation and in vitro evaluation of carrier erythrocytes for RES-targeted delivery of interferon-alpha 2b. Int. J. Pharm., 341, 125-133 (2007b). (Pubitemid 47088116)
16. Jain, S. and Jain, N. K., Engineered erythrocytes as a drug delivery system. Indian J. Pharm. Sci., 59, 275-281 (1997). (Pubitemid 28055393)
17. Jain, S., Jain, S. K., and Dixit, V. K., Magnetically guided rat erythrocytes bearing isoniazid: preparation, characterization, and evaluation. Drug Dev. Ind. Pharm., 23, 999-1006 (1997). (Pubitemid 27412607)
18. Jain, S. K., The accumulation of malonyldialdehyde, a product of fatty acid peroxidation, can disturb amino-phospholipid organization in the membrane bilayer of human erythrocytes. J. Biol. Chem., 259, 3391-3394 (1984). (Pubitemid 14170059)
19. Jaitely, V., Kanaujia, P., Venkatesan, N., Jain, S., and Vyas, S. P., Resealed erythrocytes: drug carrier potentials and biomedical applications. Indian Drugs, 33, 589-594 (1996). (Pubitemid 27041647)
20. Kaur, K., Jain, M., Reddy, R. P., and Jain, R., Quinolines and structurally related heterocycles as antimalarials. Eur. J. Med. Chem., 45, 3245-3264 (2010).
21. Ko, C. H., Li, K., Ng, P. C., Fung, K. P., Wong, R. P., Chui, K. M., Gu, G. J., Yung, E., and Fok, T. F., Pro-oxidative effects of Chinese herbal medicine on G6PD-deficient erythrocytes in vitro. Toxicol. In Vitro, 22, 1222-1227 (2008).
22. Kraus, A., Roth, H. P., and Kirchgessner, M., Supplementation with vitamin C, vitamin E or β-carotene influences osmotic fragility and oxidative damage of erythrocytes of zinc-deficient rats. J. Nutr., 127, 1290-1296 (1997). (Pubitemid 27283994)
23. Levine, R. L., Williams, J. A., Stadtman, E. R., and Shacter, E., Carbonyl assays for determination of oxidatively modified proteins. Methods Enzymol., 233, 346-357 (1994).
24. Lewis, D. A. and Alpar, H. O., Therapeutic possibilities of drugs encapsulated in erythrocytes. Int. J. Pharm., 22, 137-146 (1984). (Pubitemid 15187767)
25. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J., Protein measurement with the Folin phenol reagent. J. Biol. Chem., 193, 265-275 (1951).
26. Mandal, D., Moitra, P. K., Saha, S., and Basu, J., Caspase 3 regulates phosphatidylserine externalization and phagocytosis of oxidatively stressed erythrocytes. FEBS Lett., 513, 184-188 (2002). (Pubitemid 34251261)
27. Matovcik, L. M., Junga, I. G., and Schrier, S. L., Drug-induced endocytosis of neonatal erythrocytes. Blood, 65, 1056-1063 (1985). (Pubitemid 15121925)
28. Mayorga, P., Deharo, E., Puisieux, F., and Couarraze, G., Interpretation and prediction of plasma levels of prim-aquine following transdermal delivery in Swiss mice. Int. J. Pharm., 155, 99-107 (1997). (Pubitemid 27368127)
29. Nishi, K. K. and Jayakrishnan, A., Preparation and in vitro evaluation of primaquine-conjugated gum arabic micro-spheres. Biomacromolecules, 5, 1489-1495 (2004). (Pubitemid 39089754)
30. Ohkawa, H., Ohishi, N., and Yagi, K., Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem., 95, 351-358 (1979). (Pubitemid 9194347)
31. Pandey, K. B., Mishra, N., and Rizvi, S. I., Protective role of myricetin on markers of oxidative stress in human erythrocytes subjected to oxidative stress. Nat. Prod. Commun., 4, 221-226 (2009).
32. Patel, P. D., Dand, N., Hirlekar, R. S., and Kadam, V. J., Drug loaded erythrocytes: as novel drug delivery system. Curr. Pharm. Des., 14, 63-70 (2008). (Pubitemid 351266985)
33. Robaszkiewicz, A., Bartosz, G., and Soszynéski, M., N-chloroamino acids cause oxidative protein modifications in the erythrocyte membrane. Mech. Ageing Dev., 129, 572-579 (2008).
34. Rodrigues, J. M., Fessi, H., Bories, C., Puisieux, F., and Devissaguet, J.-P., Primaquine-loaded poly(lactide) nano-particles: physicochemical study and acute tolerance in mice. Int. J. Pharm., 126, 253-260 (1995). (Pubitemid 26015640)
35. Schrier, S. L., Junga, I., Krueger, J., and Johnson, M., Requirements of drug-induced endocytosis by intact human erythrocytes. Blood Cells, 4, 339-359 (1978).
36. Schrier, S. L., Johnson, M., Junga, I., and Krueger, J., Calcium distribution within human erythrocytes during endocytosis. Blood, 56, 677-682 (1980). (Pubitemid 10005673)
37. Schrier, S. L., Junga, I., and Ma, L., Studies on the effect of vanadate on endocytosis and shape changes in human red blood cells and ghosts. Blood, 68, 1008-1014 (1986). (Pubitemid 17186374)
38. Singh, K. K. and Vingkar, S. K., Formulation, antimalarial activity and biodistribution of oral lipid nanoemulsion of primaquine. Int. J. Pharm., 347, 136-143 (2008). (Pubitemid 350180322)
39. Stensrud, G., Sande, S. A., Kristensen, S., and Smistad, G., Formulation and characterization of primaquine loaded liposomes prepared by a pH gradient using experimental design. Int. J. Pharm., 198, 213-228 (2000). (Pubitemid 30184858)
40. Talwar, N. and Jain, N. K., Erythrocytes as carriers of primaquine-preparation: characterization and evaluation. J. Control. Release, 20, 133-141 (1992).
41. Tyurina, Y. Y., Shvedova, A. A, Kawai, K., Tyurin, V. A., Kommineni, C., Quinn, P. J., Schor, N. F., Fabisiak, J. P., and Kagan, V. E., Phospholipid signaling in apoptosis: peroxidation and externalization of phosphatidylserine. Toxicology, 148, 93-101 (2000). (Pubitemid 30621348)
42. Valbonesi, M., Bruni, R., Florio, G., Zenella, A., and Bunkens, H., Cellular contamination of plasma collected with various apheresis systems. Transfus. Apher. Sci., 24, 91-94 (2001). (Pubitemid 33062332)
43. Vale, N., Moreira, R., and Gomes, P., Primaquine revisited six decades after its discovery. Eur. J. Med. Chem., 44, 937-953 (2009).
44. Vettore, L., Zanella, A., Molaro, G. L., De Matteis, M. C., Pavesi, M., and Mariani, M., A new test for the laboratory diagnosis of spherocytosis. Acta Haematol., 72, 258-263 (1984). (Pubitemid 15222044)
45. Zwaal, R. F. and Schroit, A. J., Pathophysiologic implications of membrane phospholipids asymmetry in blood cells. Blood, 89, 1121-1132 (1997). (Pubitemid 27079974)